ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Frailty Prediction Model for Elderly Diabetic Peripheral Neuropathy Patients.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Elderly patients with diabetic peripheral neuropathy (DPN) are significantly impacted by frailty, yet frailty prediction models for this population remain underexplored. This study aims to develop and internally validate a frailty prediction model for elderly patients with DPN. Patients and Methods: A cross-sectional study design was employed, and 400 elderly DPN patients were recruited from a tertiary hospital in Guangdong Province, China, between December 2024 and July 2025. Logistic regression was employed to identify frailty risk factors and develop a prediction model and nomogram for elderly DPN patients. We evaluated the performance of the model using the area under the receiver operating characteristic (ROC) curve, abbreviated as AUC, and was further assessed through the Hosmer-Lemeshow test and calibration curves. The clinical utility of the model was assessed by decision curve analysis (DCA). Internal validation was performed using 1000 bootstrap resamples to reduce the risk of overfitting. Results: Among the 400 patients, 113 (28.25%) patients had frailty. Six factors were identified as significant predictors: age, marital status, regular exercise, PSQI score, MNA-SF score, and HADS-D score. We constructed a nomogram based on these factors. Internal validation demonstrated good performance in both discrimination and calibration, and DCA confirmed the model's clinical applicability. Conclusion: The nomogram developed in this study provides an effective tool for the early identification of elderly DPN patients at risk of frailty, thereby informing tailored preventive and intervention strategies. External validation will be conducted in future studies, and future studies will assess the model's generalizability across different regions and healthcare systems. The main predictors identified in this study include age, marital status, regular exercise, PSQI score, MNA-SF score, and HADS-D score, which significantly contribute to frailty risk in elderly DPN patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.